Concord Biotech Ltd
BSE: 543960
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY27 | Q1 FY27 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 312.31+19.9% | 260.52-6.3% | 278.13+12.6% | 247.06+21.1% | 203.99-52.5% | 429.88+76.0% | 244.22-21.3% | 310.18 |
| Other Income | 10.45-20.2% | 13.10+29.9% | 10.08-24.9% | 13.43-1.8% | 13.68+45.8% | 9.38-36.3% | 14.73+46.9% | 10.03 |
| Total Income | 322.77+18.0% | 273.61-5.1% | 288.22+10.6% | 260.49+19.7% | 217.67-50.4% | 439.27+69.6% | 258.95-19.1% | 320.21 |
| EXPENSES | ||||||||
| Expenditure | 220.85+15.4% | 191.40-1.7% | 194.64+11.2% | 174.97+9.1% | 160.43-36.9% | 254.17+59.2% | 159.63-14.6% | 186.91 |
| Tax | 26.21+24.7% | 21.02-6.7% | 22.51-0.5% | 22.62+54.2% | 14.67-66.0% | 43.16+71.0% | 25.23-27.1% | 34.59 |
| PROFIT | ||||||||
| PBT | 101.92+24.0% | 82.21-9.0% | 90.30+5.6% | 85.52+49.4% | 57.24-69.1% | 185.09+86.4% | 99.32-25.5% | 133.29 |
| Net Profit | 75.71+23.7% | 61.19-9.7% | 67.78+7.8% | 62.90+47.8% | 42.57-70.0% | 141.94+91.6% | 74.09-24.9% | 98.70 |
| KEY METRICS | ||||||||
| OPM % | 35.16%+1.70pp | 33.46%-2.11pp | 35.57%-1.08pp | 36.65%+6.55pp | 30.10%-14.20pp | 44.30%+15.13pp | 29.17%-6.25pp | 35.42% |
| NPM % | 23.46%+1.09pp | 22.37%-1.15pp | 23.52%-0.63pp | 24.15%+4.59pp | 19.56%-12.75pp | 32.31%+3.70pp | 28.61%-2.21pp | 30.82% |
| EPS | 7.24+23.8% | 5.85-9.7% | 6.48+7.8% | 6.01+47.7% | 4.07-70.0% | 13.57+91.7% | 7.08-24.9% | 9.43 |
Corporate Events
Board MeetingCONCORDBIO
202627Oct
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingCONCORDBIO
202623Sep
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingCONCORDBIO
202631Jul
Board Meeting
The 41st Annual General Meeting (AGM) of the Company is sche…
BSE Filing ↗ Board MeetingCONCORDBIO
202629May
Board Meeting
To consider and approve the audited Standalone and Consolida…
BSE Filing ↗ Board MeetingCONCORDBIO
202411Nov
Board Meeting
Approve The Standalone And Consolidated Unaudited Financial …
BSE Filing ↗